COPD

News

AZ to file COPD combo in China and Japan

AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan, based on a new set of positive phase 3 trial results.

News

COPD triple approved, can GSK maximise its revenues?

EU regulators also backed Trelegy

News

GSK and Propeller prepare to launch digital inhaler

Deal expands to a commercialisation partnership to prepare for US and Europe marketing.

News

Verona pushes on with COPD drug after £70m fundraiser

UK biotech hopes RPL554 could be a disease modifying drug.

News

After Hikma and Mylan fail, Sandoz files Advair generic in U...

FDA accepts Sandoz filing for Advair Diskus generic.

News

Chiesi backs up COPD triple therapy with real world study

Italian firm takes on mighty GSK

AZ to file COPD combo in China and Japan

COPD triple approved, can GSK maximise its revenues?

GSK and Propeller prepare to launch digital inhaler

Verona pushes on with COPD drug after £70m fundraiser

After Hikma and Mylan fail, Sandoz files Advair generic in U...

Chiesi backs up COPD triple therapy with real world study

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

COPD

Editor's Picks